Sequential Treatment with Irinotecan and Doxifluridine: Optimal Dosing Schedule in Murine Models and in a Phase I Study for Metastatic Colorectal Cancer

Publisher： Karger

E-ISSN： 1421-9794|51|1|32-39

ISSN： 0009-3157

Source： Chemotherapy, Vol.51, Iss.1, 2005-04, pp. : 32-39

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Phase I/II Study of 24-Hour Infusion of Irinotecan Combined with Oral UFT for Metastatic Colorectal Cancer

By  

Chemotherapy, Vol. 54, Iss. 2, 2008-02 ,pp. : 140-146

Karger

Access to resources Recommend Favorite

Irinotecan-Cetuximab-Bevacizumab as a Salvage Treatment in Heavily Pretreated Metastatic Colorectal Cancer Patients: A Retrospective Observational Study

By  

Chemotherapy, Vol. 57, Iss. 2, 2011-03 ,pp. : 138-144

Karger

Access to resources Recommend Favorite

Phase I/II Trial of Irinotecan and S-1 Combination Chemotherapy as a Second-Line Treatment for Advanced Colorectal Cancer

By  

Chemotherapy, Vol. 59, Iss. 5, 2014-05 ,pp. : 338-343

Karger

Access to resources Recommend Favorite

Hepatic Arterial Infusion with Irinotecan in Patients with Liver Metastases of Colorectal Cancer: Results of an Extended Phase I Study

By  

Chemotherapy, Vol. 59, Iss. 1, 2013-07 ,pp. : 66-73

Karger

Access to resources Recommend Favorite

A Phase I Study of the Combination of Temsirolimus with Irinotecan for Metastatic Sarcoma

By Verschraegen Claire F.   Movva Sujana   Ji Yongli   Schmit Berndt   Quinn Robert H.   Liem Ben   Bocklage Therese   Shaheen Monte  

Cancers, Vol. 5, Iss. 2, 2013-04 ,pp. : 418-429

MDPI

Access to resources Recommend Favorite